{"links": [{"source": 0, "target": "t6042", "value": "None"}, {"source": 0, "target": "t6046", "value": "None"}, {"source": 0, "target": "t6034", "value": "None"}, {"source": 0, "target": "t6026", "value": "None"}, {"source": 0, "target": "t6056", "value": "None"}, {"source": 0, "target": "t6061", "value": "None"}, {"source": "t6042", "target": "t6043", "value": "None"}, {"source": "t6046", "target": "t6047", "value": "None"}, {"source": "t6046", "target": "t6054", "value": "None"}, {"source": "t6034", "target": "t6035", "value": "None"}, {"source": "t6026", "target": "t6033", "value": "None"}, {"source": "t6026", "target": "t6028", "value": "None"}, {"source": "t6026", "target": "t6027", "value": "None"}, {"source": "t6056", "target": "t6057", "value": "None"}, {"source": "t6043", "target": "t6044", "value": "None"}, {"source": "t6047", "target": "t6048", "value": "None"}, {"source": "t6047", "target": "d118", "value": "None"}, {"source": "t6047", "target": "d37", "value": "None"}, {"source": "t6047", "target": "d39", "value": "None"}, {"source": "t6047", "target": "d144", "value": "None"}, {"source": "t6047", "target": "d140", "value": "None"}, {"source": "t6047", "target": "d314", "value": "None"}, {"source": "t6054", "target": "d410", "value": "None"}, {"source": "t6054", "target": "d15", "value": "None"}, {"source": "t6035", "target": "t6036", "value": "None"}, {"source": "t6035", "target": "d144", "value": "None"}, {"source": "t6028", "target": "t6029", "value": "None"}, {"source": "t6057", "target": "t6058", "value": "None"}, {"source": "t6044", "target": "t6045", "value": "None"}, {"source": "t6048", "target": "t6049", "value": "None"}, {"source": "t6048", "target": "d213", "value": "None"}, {"source": "t6036", "target": "t6037", "value": "None"}, {"source": "t6036", "target": "d333", "value": "None"}, {"source": "t6029", "target": "t6030", "value": "None"}, {"source": "t6058", "target": "t6059", "value": "None"}, {"source": "t6058", "target": "t6060", "value": "None"}, {"source": "t6049", "target": "t6050", "value": "None"}, {"source": "t6037", "target": "t6038", "value": "None"}, {"source": "t6030", "target": "t6031", "value": "None"}, {"source": "t6059", "target": "t6062", "value": "None"}, {"source": "t6060", "target": "t6062", "value": "None"}, {"source": "t6050", "target": "t6051", "value": "None"}, {"source": "t6038", "target": "t6039", "value": "None"}, {"source": "t6031", "target": "t6032", "value": "None"}, {"source": "t6051", "target": "t6052", "value": "None"}, {"source": "t6051", "target": "d215", "value": "None"}, {"source": "t6039", "target": "t6040", "value": "None"}, {"source": "t6039", "target": "t6041", "value": "None"}, {"source": "t6052", "target": "t6053", "value": "None"}, {"source": "t6053", "target": "t6055", "value": "None"}], "nodes": [{"category": "disease", "id": 0, "name": "Meningitis_and_meningococcal_septicaemia", "x": "250", "y": "350", "fixed": "true", "draggable": "true", "value": {"name": "Meningitis_and_meningococcal_septicaemia"}}, {"category": "treatment", "id": "t6042", "name": "child under 16 following bacterial meningitis or meningococcal septicaemia", "draggable": "true", "value": {"name": "child under 16 following bacterial meningitis or meningococcal septicaemia", "type": "treatment related", "time": "", "intention": "", "description": "title:child under 16 following bacterial meningitis or meningococcal septicaemia", "drug": {}}}, {"category": "treatment", "id": "t6046", "name": "child under 16 with suspected or confirmed bacterial meningitis or meningococcal septicaemia", "draggable": "true", "value": {"name": "child under 16 with suspected or confirmed bacterial meningitis or meningococcal septicaemia", "type": "treatment related", "time": "", "intention": "", "description": "title:child under 16 with suspected or confirmed bacterial meningitis or meningococcal septicaemia", "drug": {}}}, {"category": "treatment", "id": "t6034", "name": "child under 16 with suspected bacterial meningitis or meningococcal septicaemia", "draggable": "true", "value": {"name": "child under 16 with suspected bacterial meningitis or meningococcal septicaemia", "type": "treatment related", "time": "", "intention": "", "description": "title:child under 16 with suspected bacterial meningitis or meningococcal septicaemia", "drug": {}}}, {"category": "treatment", "id": "t6026", "name": "child under 16 with possible symptoms and signs of bacterial meningitis or meningococcal septicaemia", "draggable": "true", "value": {"name": "child under 16 with possible symptoms and signs of bacterial meningitis or meningococcal septicaemia", "type": "treatment related", "time": "", "intention": "", "description": "title:child under 16 with possible symptoms and signs of bacterial meningitis or meningococcal septicaemia", "drug": {}}}, {"category": "treatment", "id": "t6056", "name": "child under 16 with possible symptoms and signs of bacterial meningitis or meningococcal septicaemia", "draggable": "true", "value": {"name": "child under 16 with possible symptoms and signs of bacterial meningitis or meningococcal septicaemia", "type": "treatment related", "time": "", "intention": "", "description": "title:child under 16 with possible symptoms and signs of bacterial meningitis or meningococcal septicaemia", "drug": {}}}, {"category": "treatment", "id": "t6061", "name": "notify local authority (legal requirement)", "draggable": "true", "value": {"name": "notify local authority (legal requirement)", "type": "information and support", "time": "", "intention": "", "description": "title:notify local authority (legal requirement)head:Notify local authority of suspicion of meningitis or meningococcal septicaemiaNotify a proper officer of the local authority urgently on suspicion of meningitis or meningococcal septicaemia. This is a legal requirement under the Health Protection (Notification) Regulations 2010.Be aware of Guidance for public health management of meningococcal disease in the UK. SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {}}}, {"category": "treatment", "id": "t6043", "name": "assess follow up requirements and offer advice", "draggable": "true", "value": {"name": "assess follow up requirements and offer advice", "type": "treatment related", "time": "", "intention": "", "description": "title:assess follow-up requirements and offer advicehead:Assess follow-up requirements and offer advice Before discharging children and young people from hospital: consider their requirements for follow-up, taking into account potential sensory, neurological, psychosocial, orthopaedic, cutaneous and renal morbidities, and discuss potential long-term effects of their condition and likely patterns of recovery with the child or young person and their parents or carers, and provide them with opportunities to discuss issues and ask questions.Offer children and young people and their parents or carers: information about and access to further care immediately after discharge, and contact details of patient support organisations including meningitis charities that can offer support, befriending, in-depth information, advocacy, counselling, and written information to signpost families to further help, and advice on accessing future care.Inform the child s or young person s GP, health visitor and school nurse (for school-age children and young people) about their bacterial meningitis or meningococcal septicaemia.Healthcare professionals with responsibility for monitoring the child s or young person s health should be alert to possible late-onset sensory, neurological, orthopaedic and psychosocial effects of bacterial meningitis and meningococcal septicaemia.See NICE s recommendations on cerebral palsy in under 25s.Quality standardsThe following quality statements are relevant to this part of the interactive flowchart.12Information provision14Follow-upSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {}}}, {"category": "treatment", "id": "t6047", "name": "treatment with antibiotics", "draggable": "true", "value": {"name": "treatment with antibiotics", "type": "treatment related", "time": "", "intention": "calcium\nit is used to treat or prevent low calcium levels.", "description": "title:treatment with antibioticshead:Treatment with antibioticssubhead:Antibiotics for suspected bacterial meningitis or meningococcal diseaseTreat children and young people aged 3 months or older with suspected bacterial meningitis without delay using intravenous ceftriaxone.Treat children younger than 3 months with suspected bacterial meningitis without delay using intravenous cefotaxime plus either amoxicillin or ampicillin.Treat suspected meningococcal disease without delay using intravenous ceftriaxone.Treat children and young people with suspected bacterial meningitis who have recently travelled outside the UK or have had prolonged or multiple exposure to antibiotics (within the past 3 months) with vancomycin in addition to the above antibiotics.Where ceftriaxone is used, do not administer it at the same time as calcium-containing infusions. Instead, use cefotaxime. See the Drug Safety Update on ceftriaxone (rocephin): incompatible with solutions containing calcium.In children younger than 3 months, ceftriaxone may be used as an alternative to cefotaxime (with or without ampicillin or amoxicillin), but be aware that ceftriaxone should not be used in premature babies or in babies with jaundice, hypoalbuminaemia or acidosis as it may exacerbate hyperbilirubinaemia.If tuberculous meningitis is part of the differential diagnosis use antibiotic treatment appropriate for tuberculous meningitis in line with NICE s recommendations on managing active tuberculosis.If herpes simplex meningoencephalitis is part of the differential diagnosis give appropriate antiviral treatment.subhead:Antibiotics for specific infections in confirmed bacterial meningitisChildren and young people aged 3 months or olderTreat H influenzae type b meningitis with intravenous ceftriaxone for 10 days in total unless directed otherwise by the results of antibiotic sensitivities.Treat S pneumoniae meningitis with intravenous ceftriaxone for 14 days in total unless directed otherwise by the results of antibiotic sensitivities.Children younger than 3 monthsTreat Group B streptococcal meningitis with intravenous cefotaxime for at least 14 days. If the clinical course is complicated, for example if there is a poor response to antibiotic therapy, effusion, or abscess, or concomitant intraventricular haemorrhage in a premature baby, consider extending the duration of treatment and consulting an expert in paediatric infectious diseases. Treat bacterial meningitis due to L monocytogenes with intravenous amoxicillin or ampicillin for 21 days in total, plus gentamicin for at least the first 7 days.Treat bacterial meningitis due to Gram-negative bacilli with intravenous cefotaxime for at least 21 days unless directed otherwise by the results of antibiotic sensitivities. If the clinical course is complicated, for example if there is a poor response to antibiotic therapy, effusion, or abscess, or concomitant intraventricular haemorrhage in a premature baby, consider extending the duration of treatment and consulting an expert in paediatric infectious diseases.subhead:Antibiotics in unconfirmed bacterial meningitisIn children and young people aged 3 months or older with unconfirmed, uncomplicated but clinically suspected bacterial meningitis, treat with intravenous ceftriaxone for at least 10 days depending on symptoms and signs and course of the illness.In children younger than 3 months with unconfirmed but clinically suspected bacterial meningitis, treat with cefotaxime plus either ampicillin or amoxicillin for at least 14 days. If the clinical course is complicated, for example if there is a poor response to antibiotic therapy, effusion, or abscess, or concomitant intraventricular haemorrhage in a premature baby, consider extending the duration of treatment and consulting an expert in paediatric infectious diseases.subhead:Antibiotics for meningococcal diseaseIn children and young people with confirmed meningococcal disease, treat with intravenous ceftriaxone for 7 days in total unless directed otherwise by the results of antibiotic sensitivities.In children and young people with unconfirmed but clinically suspected meningococcal disease, treat with intravenous ceftriaxone for 7 days in total.Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.4Initiation of antibioticsSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {"calcium": "DB00884", "amoxicillin": "DB01211", "ampicillin": "DB00415", "ceftriaxone": "DB01212", "cefotaxime": "DB00493", "gentamicin": "DB00798"}}}, {"category": "treatment", "id": "t6054", "name": "additional interventions in meningococcal septicaemia", "draggable": "true", "value": {"name": "additional interventions in meningococcal septicaemia", "type": "treatment related", "time": "", "intention": "albumin\nit is used to treat or prevent low blood volume.\nit is used to treat low blood pressure.\nit is used to replace albumin in people with low blood albumin levels.\nit is used to add back fluid after fluid loss.\nit is used to treat shock.", "description": "title:additional interventions in meningococcal septicaemiahead:Additional interventions in meningococcal septicaemiasubhead:Correcting metabolic disturbancesIn children and young people with suspected or confirmed meningococcal septicaemia, anticipate, monitor and correct the following metabolic disturbances using local or national protocols: hypoglycaemia acidosis hypokalaemia hypocalcaemia hypomagnesaemia anaemia coagulopathy.subhead:Intravenous fluid resuscitationIn children and young people with suspected or confirmed meningococcal septicaemia: If there are signs of shock, give an immediate fluid bolus of 20 ml/kg sodium chloride 0.9% over 5\u201310 minutes. Give the fluid intravenously or via an intraosseous route and reassess the child or young person immediately afterwards. If the signs of shock persist, immediately give a second bolus of 20 ml/kg of intravenous or intraosseous sodium chloride 0.9% or human albumin 4.5% solution over 5\u201310 minutes. If the signs of shock still persist after the first 40 ml/kg: discuss further management with a paediatric intensivist.subhead:Vasoactive therapy for shockIf shock persists despite fluid resuscitation (more than 40 ml/kg) and treatment with either intravenous adrenaline or intravenous noradrenaline, or both, consider potential reasons (such as persistent acidosis, incorrect dilution, extravasation) and discuss further management options with a paediatric intensivist.Use local or national protocols for the administration of vasoactive agents in children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia.subhead:Adjunctive therapiesDo not use activated protein C or recombinant bacterial permeability-increasing protein in children and young people with meningococcal septicaemia.Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.9Tracheal intubation and mechanical ventilation in meningococcal septicaemiaSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {"adrenalin": "DB11124"}}}, {"category": "treatment", "id": "t6035", "name": "specific investigations and immediate treatment when petechial rash is present", "draggable": "true", "value": {"name": "specific investigations and immediate treatment when petechial rash is present", "type": "treatment related", "time": "", "intention": "ceftriaxone\nit is used to treat or prevent bacterial infections.", "description": "title:specific investigations and immediate treatment when petechial rash is presenthead:Specific investigations and immediate treatment when petechial rash is presentPerform a very careful examination for signs of meningitis or septicaemia in children and young people presenting with petechial rashes (see Table 1 Symptoms and signs of bacterial meningitis and meningococcal septicaemia).subhead:When to give intravenous ceftriaxoneGive intravenous ceftriaxone immediately to children and young people with a petechial rash if any of the following occur at any point during the assessment (these children are at high risk of having meningococcal disease): petechiae start to spread the rash becomes purpuric there are signs of bacterial meningitis there are signs of meningococcal septicaemia the child or young person appears ill to a healthcare professional.See management in secondary care in this interactive flowchart.subhead:Child with rash and feverIf a child or young person has an unexplained petechial rash and fever (or history of fever) carry out the following investigations: full blood count CRP coagulation screen blood culture whole-blood PCR for N meningitidis blood glucose blood gas.subhead:Child with rash and fever but no high-risk clinical manifestationsIn a child or young person with an unexplained petechial rash and fever (or history of fever) but none of the high-risk clinical manifestations: Treat with intravenous ceftriaxone immediately if the CRP and/or WBC count (especially neutrophil count) is raised, as this indicates an increased risk of having meningococcal disease. Be aware that while a normal CRP and normal WBC count mean meningococcal disease is less likely, they do not rule it out. The CRP may be normal and the WBC normal or low even in severe meningococcal disease. Assess clinical progress by monitoring vital signs (respiratory rate, heart rate, blood pressure, conscious level (Glasgow Coma Scale and/or APVU), temperature), capillary refill time, and oxygen saturations. Carry out observations at least hourly over the next 4\u20136 hours. If doubt remains, treat with antibiotics and admit to hospital.If the child or young person is assessed as being at low risk of meningococcal disease and is discharged after initial observation, advise parents or carers to return to hospital if the child or young person appears ill to them.subhead:Child with non-spreading rash without fever who does not appear illBe aware that in children and young people who present with a non-spreading petechial rash without fever (or history of fever) who do not appear ill to a healthcare professional, meningococcal disease is unlikely, especially if the rash has been present for more than 24 hours. In such cases consider: other possible diagnoses performing a full blood count and coagulation screen.Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.3Management of petechial rashSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {"ceftriaxone": "DB01212"}}}, {"category": "treatment", "id": "t6033", "name": "antimicrobial stewardship", "draggable": "true", "value": {"name": "antimicrobial stewardship", "type": "treatment related", "time": "", "intention": "", "description": "title:antimicrobial stewardship", "drug": {}}}, {"category": "treatment", "id": "t6028", "name": "symptoms and signs", "draggable": "true", "value": {"name": "symptoms and signs", "type": "treatment related", "time": "", "intention": "", "description": "title:symptoms and signshead:Symptoms and signsConsider bacterial meningitis and meningococcal septicaemia in children and young people who present with the symptoms and signs (see Table 1 Symptoms and signs of bacterial meningitis and meningococcal septicaemia below).  Be aware that:  some children and young people will present with mostly non-specific symptoms or signs, and the conditions may be difficult to distinguish from other less important (viral) infections presenting in this way children and young people with the more specific symptoms and signs are more likely to have bacterial meningitis or meningococcal septicaemia, and the symptoms and signs may become more severe and more specific over time.  Recognise shock and manage urgently in secondary care (see Table 2 Signs of shock below).subhead:Table 1 Symptoms and signs of bacterial meningitis and meningococcal septicaemiaCommon non-specific symptoms / signs (not always present, especially in neonates) Symptom / sign Bacterial meningitis (meningococcal meningitis and meningitis caused by other bacteria) Meningococcal disease (meningococcal meningitis and/or meningococcal septicaemia) Meningococcal septicaemia Fever Y Y Y Vomiting / nausea Y Y Y Lethargy Y Y Y Irritable / unsettled Y Y Y Ill appearance Y Y Y Refusing food / drink Y Y Y Headache Y Y Y Muscle ache / joint pain Y Y Y Respiratory symptoms / signs or breathing difficulty Y Y Y Less common non-specific symptoms / signs Symptom / sign Bacterial meningitis (meningococcal meningitis and meningitis caused by other bacteria) Meningococcal disease (meningococcal meningitis and/or meningococcal septicaemia) Meningococcal septicaemia Chills / shivering Y Y Y Diarrhoea, abdominal pain / distension Y Y Not known Sore throat / coryza or other ear, nose and throat symptoms / signs Y Y Not known More specific symptoms / signs Symptom / sign Bacterial meningitis (meningococcal meningitis and meningitis caused by other bacteria) Meningococcal disease (meningococcal meningitis and/or meningococcal septicaemia) Meningococcal septicaemia Non-blanching rasha Y Y Y Stiff neck Y Y Not known Altered mental stateb Y Y Y Capillary refill time more than 2 seconds Not known Y Y Unusual skin colour Not known Y Y Shock Y Y Y Hypotension Not known Y Y Leg pain Not known Y Y Cold hands / feet Not known Y Y Back rigidity Y Y Not known Bulging fontanellec Y Y Not known Photophobia Y Y N Kernig s sign Y Y N Brudzinski s sign Y Y N Unconsciousness Y Y Y Toxic / moribund state Y Y Y Paresis Y Y N Focal neurological deficit including cranial nerve involvement and abnormal pupils Y Y N Seizures Y Y N Y: symptom or sign present;N: symptom or sign not present;Not known: not reported in the evidence.a Be aware that a rash may be less visible in darker skin tones \u2013 check soles of feet, palms or hands and conjunctivae;b Includes confusion, delirium and drowsiness, and impaired consciousness;c Only relevant in children under 2 years.subhead:Table 2 Signs of shockSigns of shock include: capillary refill time more than 2 seconds unusual skin colour tachycardia and/or hypotension respiratory symptoms or breathing difficulty leg pain cold hands/feet toxic/moribund state altered mental state/decreased conscious level poor urine output SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {}}}, {"category": "treatment", "id": "t6027", "name": "babies in neonatal units within 72 hours of birth", "draggable": "true", "value": {"name": "babies in neonatal units within 72 hours of birth", "type": "treatment related", "time": "", "intention": "", "description": "title:babies in neonatal units within 72 hours of birthhead:Babies in neonatal units within 72 hours of birthFor guidance on antibiotics for preventing and treating bacterial infection in newborn babies within 72 hours of birth in a neonatal unit see NICE s recommendations on antibiotic treatment and monitoring for suspected meningitis in newborn babies in a neonatal unit.", "drug": {}}}, {"category": "treatment", "id": "t6057", "name": "assessment", "draggable": "true", "value": {"name": "assessment", "type": "treatment related", "time": "", "intention": "", "description": "title:assessmenthead:Assessment of a child under 16 with suspected bacterial meningitis or meningococcal septicaemiaBe alert to the possibility of bacterial meningitis or meningococcal septicaemia when assessing children or young people with acute febrile illness.Healthcare professionals should be aware that classical signs of meningitis (neck stiffness, bulging fontanelle, high-pitched cry) are often absent in infants with bacterial meningitis.This recommendation is from feverish illness in children (NICE guideline CG47).Be aware that children and young people with bacterial meningitis commonly present with non-specific symptoms and signs, including fever, vomiting, irritability, and upper respiratory tract symptoms. Some children with bacterial meningitis present with seizures.Consider other non-specific features of the child s or young person s presentation, such as: the level of parental or carer concern (particularly compared with previous illness in the child or young person or their family) how quickly the illness is progressing, and clinical judgement of the overall severity of the illness.In children and young people with suspected bacterial meningitis or meningococcal septicaemia, undertake and record physiological observations of heart rate, respiratory rate, oxygen saturations, blood pressure, temperature, perfusion (capillary refill) and neurological assessment (for example the APVU scale) at least hourly.Healthcare professionals should be trained in the recognition and management of meningococcal disease.For further information see Table 1 Symptoms and signs of bacterial meningitis and meningococcal septicaemia.Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.2MonitoringSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {}}}, {"category": "treatment", "id": "t6044", "name": "perform audiological assessment", "draggable": "true", "value": {"name": "perform audiological assessment", "type": "treatment related", "time": "", "intention": "", "description": "title:perform audiological assessmenthead:Perform audiological assessmentOffer a formal audiological assessment as soon as possible, preferably before discharge, within 4 weeks of being fit to test.Offer children and young people with a severe or profound deafness an urgent assessment for cochlear implants as soon as they are fit to undergo testing (further guidance on the use of cochlear implants for severe to profound deafness can be found in the NICE technology appraisal guidance on cochlear implants for children and adults with severe to profound deafness).Children and young people should be reviewed by a paediatrician with the results of their hearing test 4\u20136 weeks after discharge from hospital to discuss morbidities associated with their condition and offered referral to the appropriate services. The following morbidities should be specifically considered: hearing loss (with the child or young person having undergone an urgent assessment for cochlear implants as soon as they are fit) orthopaedic complications (damage to bones and joints) skin complications (including scarring from necrosis) psychosocial problems neurological and developmental problems renal failure.Quality standardsThe following quality statements are relevant to this part of the interactive flowchart.13Audiological assessment14Follow-upSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {}}}, {"category": "treatment", "id": "t6048", "name": "when to treat with corticosteroids", "draggable": "true", "value": {"name": "when to treat with corticosteroids", "type": "treatment related", "time": "", "intention": "dexamethasone\ndexamethasone is used to treat many different conditions such as allergic disorders, skin conditions, ulcerative colitis, arthritis, lupus, psoriasis, or breathing disorders.\ndexamethasone may also be used for purposes not listed in this medication guide.\nshould dexamethasone sodim phosphate be used to treat upper respiratory tract infection?", "description": "title:when to treat with corticosteroidshead:When to treat with corticosteroidssubhead:Corticosteroids in bacterial meningitisDo not use corticosteroids in children younger than 3 months with suspected or confirmed bacterial meningitis.Give dexamethasone (0.15 mg/kg to a maximum dose of 10 mg, four times daily for 4 days)The dosage given in the recommendation is based on high-quality evidence and is consistent with established clinical practice (see the full guideline for CG102 for further details). The guideline will assume that prescribers will use a drug s SPC to inform their decisions for individual patients. Dexamethasone does not have UK marketing authorisation for use at the dose specified in the recommendation. Such use is an off-label use. Informed consent should be obtained and documented in line with normal standards in emergency care. for suspected or confirmed bacterial meningitis as soon as possible if lumbar puncture reveals any of the following: frankly purulent CSF CSF WBC count greater than 1000/microlitre raised CSF WBC count with protein concentration greater than 1 g/litre bacteria on Gram stain.If tuberculous meningitis is in the differential diagnosis, see NICE s recommendations on managing active tuberculosis before administering steroids, because steroids may be harmful if given without antituberculous therapy.If dexamethasone was not given before or with the first dose of antibiotics, but was indicated, try to administer the first dose within 4 hours of starting antibiotics, but do not start dexamethasone more than 12 hours after starting antibiotics.After the first dose of dexamethasone discuss the decision to continue dexamethasone with a senior paediatrician.subhead:Corticosteroids in meningococcal septicaemiaDo not treat with high-dose corticosteroids (defined as dexamethasone 0.6 mg/kg/day or an equivalent dose of other corticosteroids).In children and young people with shock that is unresponsive to vasoactive agents, steroid replacement therapy using low-dose corticosteroids (hydrocortisone 25 mg/m2 four times daily) should be used only when directed by a paediatric intensivist.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {"dexamethasone": "DB01234"}}}, {"category": "treatment", "id": "t6036", "name": "blood tests", "draggable": "true", "value": {"name": "blood tests", "type": "treatment related", "time": "", "intention": "hold\nit is used to relieve coughing.\nif you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for", "description": "title:blood testshead:Blood tests for bacterial meningitis and meningococcal diseasesubhead:C-reactive protein test and white blood cell count for suspected bacterial meningitisIn children and young people with suspected bacterial meningitis, perform a CRP and WBC count: If the CRP and/or white blood cell count is raised and there is a non-specifically abnormal CSF (for example consistent with viral meningitis), treat as bacterial meningitis. Be aware that a normal CRP and WBC count does not rule out bacterial meningitis. Regardless of the CRP and WBC count, if no CSF is available for examination or if the CSF findings are uninterpretable, manage as if the diagnosis of meningitis is confirmed.subhead:Polymerase chain reaction test for bacterial meningitis and meningococcal disease Perform whole blood real-time PCR testing (EDTA sample) for N meningitidis to confirm a diagnosis of meningococcal disease.The PCR blood sample should be taken as soon as possible because early samples are more likely to be positive.Use PCR testing of blood samples from other hospital laboratories if available, to avoid repeating the test.Be aware that a negative blood PCR test result for N meningitidis does not rule out meningococcal disease.Submit CSF to the laboratory to hold for PCR testing for N meningitidis and S pneumoniae, but only perform the PCR testing if the CSF culture is negative.Be aware that CSF samples taken up to 96 hours after admission to hospital may give useful results.Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.7Blood testsSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {"hold": "DB00748"}}}, {"category": "treatment", "id": "t6029", "name": "pre hospital assessment and management", "draggable": "true", "value": {"name": "pre hospital assessment and management", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:pre-hospital assessment and management", "drug": {}}}, {"category": "treatment", "id": "t6058", "name": "emergency transfer to secondary care", "draggable": "true", "value": {"name": "emergency transfer to secondary care", "type": "cancer ralated", "time": "", "intention": "", "description": "title:emergency transfer to secondary carehead:Emergency transfer to secondary carePrimary care healthcare professionals should transfer children and young people with suspected bacterial meningitis or suspected meningococcal septicaemia to secondary care as an emergency by telephoning 999.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {}}}, {"category": "treatment", "id": "t6045", "name": "immune testing following meningococcal disease", "draggable": "true", "value": {"name": "immune testing following meningococcal disease", "type": "treatment related", "time": "", "intention": "", "description": "title:immune testing following meningococcal diseasehead:Immune testing following meningococcal diseaseTest children and young people for complement deficiency if they have had either:  more than one episode of meningococcal disease, or one episode of meningococcal disease caused by serogroups other than B (for example A, C, Y, W135, X, 29E), or meningococcal disease caused by any serogroup and a history of other recurrent or serious bacterial infections.Children and young people with recurrent episodes of meningococcal disease should be assessed by a specialist in infectious disease or immunology.Do not test children and young people for complement deficiency who have had either: a single episode of meningococcal disease caused by serogroup B meningococcus, or unconfirmed meningococcal disease.Discuss appropriate testing for complement deficiency with local immunology laboratory staff.If a child or young person who has had meningococcal disease has a family history of meningococcal disease or complement deficiency, test the child or young person for complement deficiency.If a child or young person who has had meningococcal disease is found to have complement deficiency, test their parents and siblings for complement deficiency.Refer children and young people with complement deficiency to a healthcare professional with expertise in the management of the condition.Do not test children and young people for immunoglobulin deficiency if they have had meningococcal disease, unless they have a history suggestive of an immunodeficiency (that is, a history of serious, persistent, unusual, or recurrent infections).SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {}}}, {"category": "treatment", "id": "t6049", "name": "managing seizures and raised intracranial pressure", "draggable": "true", "value": {"name": "managing seizures and raised intracranial pressure", "type": "treatment related", "time": "", "intention": "", "description": "title:managing seizures and raised intracranial pressurehead:Managing seizures and raised intracranial pressuresubhead:Managing seizuresUse local or national protocols for management of seizures in children and young people with suspected bacterial meningitis or meningococcal septicaemia.subhead:Managing raised cranial pressureUse local or national protocols to treat raised intracranial pressure.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {}}}, {"category": "treatment", "id": "t6037", "name": "cranial ct examination", "draggable": "true", "value": {"name": "cranial ct examination", "type": "treatment related", "time": "", "intention": "", "description": "title:cranial ct examinationhead:Cranial CT examination for suspected bacterial meningitisUse clinical assessment and not cranial CT, to decide whether it is safe to perform a lumbar puncture. CT is unreliable for identifying raised intracranial pressure.If a CT scan has been performed, do not perform a lumbar puncture if the CT scan shows radiological evidence of raised intracranial pressure.In children and young people with a reduced or fluctuating level of consciousness (Glasgow Coma Scale score less than 9 or a drop of 3 or more) or with focal neurological signs, perform a CT scan to detect alternative intracranial pathology.Do not delay treatment to undertake a CT scan.Clinically stabilise children and young people before CT scanning.If performing a CT scan consult an anaesthetist, paediatrician or intensivist.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {}}}, {"category": "treatment", "id": "t6030", "name": "diagnosis in secondary care", "draggable": "true", "value": {"name": "diagnosis in secondary care", "type": "cancer ralated", "time": "", "intention": "", "description": "title:diagnosis in secondary care", "drug": {}}}, {"category": "treatment", "id": "t6059", "name": "when non blanching rash is present", "draggable": "true", "value": {"name": "when non blanching rash is present", "type": "treatment related", "time": "", "intention": "", "description": "title:when non-blanching rash is presenthead:When non-blanching rash is presentGive parenteral antibiotics (intramuscular or intravenous benzylpenicillin) at the earliest opportunity, either in primary or secondary care, but do not delay urgent transfer to hospital to give the parenteral antibiotics.Withhold benzylpenicillin only in children and young people who have a clear history of anaphylaxis after a previous dose; a history of a rash following penicillin is not a contraindication.Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.4Initiation of antibioticsSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {}}}, {"category": "treatment", "id": "t6060", "name": "when non blanching rash is absent", "draggable": "true", "value": {"name": "when non blanching rash is absent", "type": "treatment related", "time": "", "intention": "", "description": "title:when non-blanching rash is absenthead:When non-blanching rash is absentTransfer children and young people with suspected bacterial meningitis without non-blanching rash directly to secondary care without giving parenteral antibiotics.If urgent transfer to hospital is not possible (for example, in remote locations or adverse weather conditions), administer antibiotics to children and young people with suspected bacterial meningitis.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {}}}, {"category": "treatment", "id": "t6050", "name": "respiratory support", "draggable": "true", "value": {"name": "respiratory support", "type": "treatment related", "time": "", "intention": "", "description": "title:respiratory supporthead:Respiratory support in confirmed bacterial meningitis or meningococcal septicaemiaIn self-ventilating children and young people with signs of respiratory distress, administer 15-litre face mask oxygen via a reservoir rebreathing mask.If there is a threatened loss of airway patency, implement airway-opening manoeuvres, and start bag\u2013valve mask ventilation in preparation for tracheal intubation.A healthcare professional with expertise in paediatric airway management should undertake tracheal intubation.Be aware that children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia are very ill and at grave risk of sudden deterioration during intubation. Anticipate aspiration, pulmonary oedema or worsening shock during intubation. Ensure that they are nil by mouth from admission to hospital and that the following are available before intubation: facilities to administer fluid boluses appropriate vasoactive drugs access to a healthcare professional experienced in the management of critically ill children.Undertake tracheal intubation and mechanical ventilation for the following indications: threatened (for example, loss of gag reflex), or actual loss of airway patency the need for any form of assisted ventilation, for example bag\u2013mask ventilation clinical observation of increasing work of breathing hypoventilation or apnoea features of respiratory failure, including: continuing shock following infusion of a total of 40 ml/kg of resuscitation fluid signs of raised intracranial pressure impaired mental status: control of intractable seizures need for stabilisation and management to allow brain imaging or transfer to the paediatric intensive care unit or another hospital.Use local or national protocols for intubation.Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.9Tracheal intubation and mechanical ventilation in meningococcal septicaemiaSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {}}}, {"category": "treatment", "id": "t6038", "name": "lumbar puncture and cerebrospinal fluid examination", "draggable": "true", "value": {"name": "lumbar puncture and cerebrospinal fluid examination", "type": "treatment related", "time": "", "intention": "", "description": "title:lumbar puncture and cerebrospinal fluid examinationhead:Lumbar puncture and CSF examination for suspected bacterial meningitisPerform a lumbar puncture as a primary investigation unless this is contraindicated.Do not allow lumbar puncture to delay the administration of parenteral antibiotics.CSF examination should include WBC count and examination, total protein and glucose concentrations, Gram stain and microbiological culture. A corresponding laboratory-determined blood glucose concentration should be measured.In children and young people with suspected meningitis or suspected meningococcal disease, perform a lumbar puncture unless any of the following contraindications are present: signs suggesting raised intracranial pressure shock (see Table 2 Signs of shock) extensive or spreading purpura after convulsions until stabilised coagulation abnormalities local superficial infection at the lumbar puncture site respiratory insufficiency (lumbar puncture is considered to have a high risk of precipitating respiratory failure in the presence of respiratory insufficiency).In children and young people with suspected bacterial meningitis, if contraindications to lumbar puncture exist at presentation consider delaying lumbar puncture until there are no longer contraindications. Delayed lumbar puncture is especially worthwhile if there is diagnostic uncertainty or unsatisfactory clinical progress.CSF WBC counts, total protein and glucose concentrations should be made available within 4 hours to support the decision regarding adjunctive steroid therapy.Start antibiotic treatment for bacterial meningitis if the CSF WBC count is abnormal: in neonates at least 20 cells/microlitre (be aware that even if fewer than 20 cells/microlitre, bacterial meningitis should still be considered if other symptoms and signs are present (see Table 1 Symptoms and signs of bacterial meningitis and meningococcal septicaemia in this interactive flowchart) in older children and young people more than 5 cells/microlitre or more than 1 neutrophil/microlitre, regardless of other CSF variables.See treatment with antibiotics in this interactive flowchart.In children and young people with suspected bacterial meningitis, consider alternative diagnoses if the child or young person is significantly ill and has CSF variables within the accepted normal ranges.Consider herpes simplex encephalitis as an alternative diagnosis.If CSF white cell count is increased and there is a history suggesting a risk of tuberculous meningitis, evaluate for the diagnosis of tuberculous meningitis in line with NICE s recommendations on assessing for active tuberculosis.Perform a repeat lumbar puncture in neonates with: persistent or re-emergent fever deterioration in clinical condition new clinical findings (especially neurological findings) or persistently abnormal inflammatory markers.Do not perform a repeat lumbar puncture in neonates: who are receiving the antibiotic treatment appropriate to the causative organism and are making a good clinical recovery before stopping antibiotic therapy if they are clinically well.Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.5Lumbar puncture for suspected bacterial meningitis6CSF microscopy for suspected bacterial meningitisSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {}}}, {"category": "treatment", "id": "t6031", "name": "management in secondary care", "draggable": "true", "value": {"name": "management in secondary care", "type": "cancer ralated", "time": "", "intention": "", "description": "title:management in secondary care", "drug": {}}}, {"category": "treatment", "id": "t6062", "name": "diagnosis in secondary care", "draggable": "true", "value": {"name": "diagnosis in secondary care", "type": "cancer ralated", "time": "", "intention": "", "description": "title:diagnosis in secondary care", "drug": {}}}, {"category": "treatment", "id": "t6051", "name": "fluid management", "draggable": "true", "value": {"name": "fluid management", "type": "treatment related", "time": "", "intention": "dextrose\nhypertonic dextrose injections (concentration >5%) are used to provide adequate calories in a minimal volume of water.a", "description": "title:fluid managementhead:Fluid management in suspected or confirmed bacterial meningitisAssess for all of the following: signs of shock (see Table 2 Signs of shock) raised intracranial pressure signs of dehydration.For assessment of shock and hydration, see symptoms and signs of clinical dehydration and shock in NICE s recommendations on diarrhoea and vomiting in children.If present, correct dehydration using enteral fluids or feeds, or intravenous isotonic fluids (for example, sodium chloride 0.9% with glucose 5% or sodium chloride 0.9% with dextrose 5%).Do not restrict fluids unless there is evidence of: raised intracranial pressure, or increased antidiuretic hormone secretion (see the National Patient Safety Agency patient safety alert 22 Reducing the risk of hyponatraemia when administering intravenous infusions to children (2007)).Give full-volume maintenance fluids to avoid hypoglycaemia and maintain electrolyte balance.Use enteral feeds as maintenance fluid if tolerated.If intravenous maintenance fluid is required, use isotonic fluids (for example, sodium chloride 0.9% with glucose 5% or sodium chloride 0.9% with dextrose 5%). In neonates, use glucose 10% and added sodium chloride for maintenance.Monitor fluid administration and urine output to ensure adequate hydration and avoid overhydration.Monitor electrolytes and blood glucose regularly (at least daily while the child or young person is receiving intravenous fluids).If there are signs of raised intracranial pressure or evidence of shock, initiate emergency management for these conditions and discuss ongoing fluid management with a paediatric intensivist.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {}}}, {"category": "treatment", "id": "t6039", "name": "skin samples", "draggable": "true", "value": {"name": "skin samples", "type": "treatment related", "time": "", "intention": "", "description": "title:skin sampleshead:Skin samplesDo not use any of the following techniques when investigating for possible meningococcal disease: skin scrapings, skin biopsies, petechial or purpuric lesion aspirates (obtained with a needle and syringe).SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {}}}, {"category": "treatment", "id": "t6032", "name": "discharge and follow up", "draggable": "true", "value": {"name": "discharge and follow up", "type": "treatment related", "time": "", "intention": "", "description": "title:discharge and follow-up", "drug": {}}}, {"category": "treatment", "id": "t6052", "name": "monitoring for deterioration", "draggable": "true", "value": {"name": "monitoring for deterioration", "type": "treatment related", "time": "", "intention": "", "description": "title:monitoring for deteriorationhead:Monitoring for deteriorationMonitor children and young people closely after admission to hospital for signs of deterioration (monitor respiration, pulse, blood pressure, oxygen saturation and Glasgow Coma Scale score).Be aware that children and young people with meningococcal disease can deteriorate rapidly, regardless of the results of any initial assessment of severity.Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.2MonitoringSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {}}}, {"category": "treatment", "id": "t6040", "name": "management in secondary care", "draggable": "true", "value": {"name": "management in secondary care", "type": "cancer ralated", "time": "", "intention": "", "description": "title:management in secondary care", "drug": {}}}, {"category": "treatment", "id": "t6041", "name": "non meningococcal septicaemia", "draggable": "true", "value": {"name": "non meningococcal septicaemia", "type": "treatment related", "time": "", "intention": "", "description": "title:non-meningococcal septicaemiahead:Non-meningococcal septicaemiaSee NICE s recommendations on sepsis.", "drug": {}}}, {"category": "treatment", "id": "t6053", "name": "resuscitation and transfer to tertiary care", "draggable": "true", "value": {"name": "resuscitation and transfer to tertiary care", "type": "treatment related", "time": "", "intention": "", "description": "title:resuscitation and transfer to tertiary carehead:Resuscitation and transfer to tertiary careChildren and young people who need resuscitation should be discussed with a paediatric intensivist as soon as possible.Transfer of children and young people to tertiary care should be undertaken by an experienced paediatric intensive care retrieval team comprising medical and nursing staff.Quality standardsThe following quality statements are relevant to this part of the interactive flowchart.11Transfer to intensive careSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG102", "drug": {}}}, {"category": "treatment", "id": "t6055", "name": "discharge and follow up", "draggable": "true", "value": {"name": "discharge and follow up", "type": "treatment related", "time": "", "intention": "", "description": "title:discharge and follow-up", "drug": {}}}, {"category": "drug", "id": "d118", "name": "calcium", "draggable": "true", "value": {"name": "calcium", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d37", "name": "amoxicillin", "draggable": "true", "value": {"name": "amoxicillin", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d39", "name": "ampicillin", "draggable": "true", "value": {"name": "ampicillin", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d144", "name": "ceftriaxone", "draggable": "true", "value": {"name": "ceftriaxone", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d140", "name": "cefotaxime", "draggable": "true", "value": {"name": "cefotaxime", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d314", "name": "gentamicin", "draggable": "true", "value": {"name": "gentamicin", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d410", "name": "albumin", "draggable": "true", "value": {"name": "albumin", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d15", "name": "adrenalin", "draggable": "true", "value": {"name": "adrenalin", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d213", "name": "dexamethasone", "draggable": "true", "value": {"name": "dexamethasone", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d333", "name": "hold", "draggable": "true", "value": {"name": "hold", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d215", "name": "dextrose", "draggable": "true", "value": {"name": "dextrose", "time": "None", "period": "None", "dosage": "None"}}]}